(3 years 2 months) Head of Bioanalytical Services (Biologics/Biosimilars CDRO) - Midas North America Head of Pharmaceutical Ingredients Business - Midas North America

Managing key global biologic/injectable partners for a leader in pharmaceutical containment and delivery solutions. Sales budget responsibility - $120 million topline for FY’22 o Full responsibility for all sales, marketing, and business development activity at the multinational accounts. o Enterprise relationship and SRM lead per global governance teams – big pharma innovators and injectable fill/finish CDMO. Lead multi-disciplinary teams to sell large business solutions, entering into multi-year agreements, requiring navigating extreme complexity in a highly regulated environment o Successfully built, negotiated, and executed 2 Master Supply Agreements in the first 8 months, with 2 global “top 10” life science companies – annual value $65 million/year o Integration with key decision makers/C-suite at partners, to align demand planning/forecasting in support of operating profit targets and pricing strategies Developed a 5-10 year strategic growth plan, which required strong integration with key R&D stakeholders o Complete pipeline overhaul securing participation in early clinical and late clinical phase programs o Project management and oversight of all regulatory and quality requirements o Tech transfer program oversight, with support of technical development/ MS&T colleagues o Executed a number of 3-way CDA discussions involving key CDMO partners Responsible for organizing and leading the Global Account team o Including regional/local key Account Managers in different geographies o Pulling in representatives from the different functions involved in the key account strategy and interacting with the customer (Quality Assurance, RA,Operations, R&D, etc).

(1 year 4 months) Managing the North American subsidiary for a multinational pharmaceutical & chemical manufacturer, based out of Yardley, PA. Reporting to President of Specialty Ingredients BU, and President of Advanced Intermediates BU, out of India. P&L responsibility for Jubilant USA office - $32 million topline budget for FY’22. o Commercial focus on new product development, pipeline building, and strategic alliance creation o Over 100+ new development project inquiries/RFPs from new customers, for the Specialty Ingredients BU in first 12 months o Tripled the topline for the project pipeline to over $50 million+. o 110%+ to budget in 2021, with initial growth target of 20% YoYo Significantly contributed to new US asset CAPEX exploration and budgeting Complete administrative responsibility - Operations/Accounting/HR/Legal/ Compliance o Developed new systems to increase operational efficiency of the business o Cleared up a significant backlog of AP issues, hindering cooperation with new and existing vendors o Maximized cash flow to maintain less than 10% of total AR greater than 30 days past due o Full oversight of domestic logistics and in-land claim handling o Handled all aspects of budgeting, forecasting, and inventory controls for the business o Key Person for statutory compliance matters Full commercial responsibility for the 3 business units represented in the Western Hemisphere – SI, AI, LSC. o Key customer segments – Pharmaceutical (CDMO/biotech/innovators/generics), Nutritional, Personal Care, Food & Beverage, Fine Chemicals, Carbon Capture, Oil Field, Agro-actives. Managed a cross functional team with support of direct and indirect reports. o Operations Manager, Controller, Sr. Manager of BD, and two Heads of Sales o Created and revised JDs/functions per business needs - hired, trained, developed senior team members o Matrix cooperation with Indian support team – logistics, accounting, HR, product development, R&D

The Head of Global Food & Beverage Ingredients BU, with cross-functional activity and responsibility in Nutritional/Supplement Ingredients BU. Reporting directly to the President. P&L for the F&B BU – $15 million/year topline business unit, and close to $35 million in the pipeline. o Building up the business unit from scratch – identifying customers, products, and partnering suppliers. o All aspects of pricing, global contracting, supply agreements with multinational accounts. o Providing Executive Team with recommendations on attractiveness of new opportunities. o Developing a strategy for tradeshow/conference attendance. o Responsible for all aspects of primary and secondary market research, as well as key account execution of sales and business development strategy. o Global coverage and travel including EU and Asia. o Recruitment and hiring of a National Manager, due to the fast growth of the business unit. o One of the members of the marketing team, responsible to the redesign and build out of the new website/marketing tools, with the assistance of a third- party creative agency. o Coaching and mentorship of overseas colleagues to establish very complex and nuanced agreements. o Global supply chain and operations expertise – from regulatory (FDA/GMP) to logistic “know how”.

4 years 8 months (2 years 6 months) The position is a promotion and a part of the global Corporate Business Development team, reporting directly to Senior VP of Corporate Business Development. Primary markets covered – NA, EU, and Japan. o Managing a multimillion dollar commercial portfolio of strategic projects in US. o Notably grew “Diagnostic Chemicals” sub-BU revenue by 30% and GP by 25% for FY ’17, ($2.5 million+), by completing supply chain overhaul to optimize profitability/sell off stock/renegotiate contractual obligations with the manufacturer. o Head of Corporate Intelligence – specific focus on global API/future generic drug due diligence. Complete project management oversight with a focus on contracting, forecasting, and negotiations. o Head of Aceto Animal Health - Established a new business unit with a complete pipeline, focusing on veterinary API and FDF opportunities for regulated/non-regulated markets. o Directed numerous key initiatives for the sales force in EU, through completion of customer segmentation, opportunity isolation, time/territory management plans, sales training, and creation of marketing materials. o Independently closed 12 new projects with double digit margins in 2016/2017, adding 5% of total revenue for US Pharma Intermediates business ($12 million+ BU). o Created numerous new global partnerships (territory rights/customerprotection agreements) with Asian manufacturers for FY ‘17– China/India. o Established a critical partnership with a third party in Ukraine for pharma ingredients/fine chemicals. o Initiated 15 new generic programs with various customers in Japan, through a local alliance with a Japanese partner. o Complete knowledge of IMS, IPD, Thomson Reuters, FDA Orange/Green books, US DMF/EDQM CEP databases.

The position is a promotion, reporting directly to VP of Sales. Responsible for all sales operations in North America and Japan. o Addition and independent management of "Diagnostic Chemicals" book of business. o Project management with existing accounts – purchasing/sales/marketing. o Global contracting. o Management and supervision of Associate Managers, and a Service Representative. o Independent new business development and strategic account management in Japan. o Management of numerous projects with Brazilian customers - Generic and CMO. o Increased domestic and international travel responsibilities. o Forecasting/pipeline tracking (~$20 million-dollar business unit) o Leadership development.

(1 year 7 months) Responsible for supporting all sales operations in North America. o Negotiated and secured a new $2 million-dollar annual contract in the first year. o Achieved major penetration of every strategic account with at least two new projects. o Initiated over 100+ brand new projects with new and existing accounts. o Established a multimillion dollar pipeline for the next 2-3 years. o Conducted business trips to India, China, Mexico, Japan, and Europe. o Developed and trained multiple new hire employees.

(2 years 6 months) The position is a promotion. Responsible for sales of 2 OR based gynecological devices, to hospitals and ASCs in NYC. Ranked #2 in the North East for Essure and Thermachoice III sales.

(1 year 5 months) Responsible for promoting 8 pharmaceutical products at the same time to Obstetrics, Gynecology, Stone Disease, Hematology, Nephrology, Urology, pharmacies, 5 state hospitals, and out-patient clinics. o Winner of a National “Drive Share Challenge” Contest o #1 in the North East post new product launch - Uribel